MYX vs SNT

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

MYX

M PHARMA FPO [MYX]

51MEDIUM

SNT

SYNTARA FPO [SNT]

51MEDIUM

Score Breakdown

MYX SNT
Technical
51
35
Catalyst
53
46
Sentiment
50
50
Fundamental
85
70
Momentum
38
47
Risk Gate
42
37

Key Metrics

MYX Metric SNT
$233.2MMarket Cap$45.1M
291KAvg Volume (20d)3.4M
+2.5%Short InterestN/A
$6.50052-Week High$0.066
$2.04052-Week Low$0.019
-0.7%Daily Change-4.4%
$2.810Reference Price$0.022
-20.6%ROE-90.5%
-20.4%Profit Margin-147.5%

Active Signals

MYX Signals

Beating the Small Ords index — relative strength of 1.29, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.6x)
EPS estimates revised upward (+10pts)
Near 52-week low (19% of range)
CANSLIM I: Institutional ownership (36%)
Deeply negative margins (-20%)

SNT Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Watch out — volume is flowing out even as price holds up. Distribution pattern
Drifting lower — down 4.3% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Low cash runway (4 quarters) - dilution risk
Moderate P/S ratio (6.0x)
Moderate revenue growth (+7%)

Ask Scout AI to compare MYX and SNT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

NXN vs SLD →MYX vs SLD →MYX vs NXN →SNT vs TRI →SLD vs TRI →
MYX Full Analysis → SNT Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).